Medical Care
Global Modified Antibody Market Research Report 2025
- Sep 24, 25
- ID: 521217
- Pages: 90
- Figures: 96
- Views: 5
Report Scope
This report aims to provide a comprehensive presentation of the global market for Modified Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Modified Antibody.
The Modified Antibody market size, estimations, and forecasts are provided in terms of sales volume (μl) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Modified Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Modified Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
RevMAb Biosciences
Thermo Fisher Scientific
BioCat GmbH
Merck
ProteoGenix
Biorbyt
Cusabio
Rockland
Proteintech
PTM BIO
Elabscience Biotechnology
AtaGenix
Segment by Type
Histone Modification Antibodies
Non-Histone Modification Antibodies
Segment by Application
Cancer Treatment
Immunopathy Treatment
Diagnosis
Scientific Research
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Modified Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Modified Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Modified Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Modified Antibody.
The Modified Antibody market size, estimations, and forecasts are provided in terms of sales volume (μl) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Modified Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Modified Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
RevMAb Biosciences
Thermo Fisher Scientific
BioCat GmbH
Merck
ProteoGenix
Biorbyt
Cusabio
Rockland
Proteintech
PTM BIO
Elabscience Biotechnology
AtaGenix
Segment by Type
Histone Modification Antibodies
Non-Histone Modification Antibodies
Segment by Application
Cancer Treatment
Immunopathy Treatment
Diagnosis
Scientific Research
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Modified Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Modified Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Modified Antibody Market Overview
1.1 Product Definition
1.2 Modified Antibody by Type
1.2.1 Global Modified Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Histone Modification Antibodies
1.2.3 Non-Histone Modification Antibodies
1.3 Modified Antibody by Application
1.3.1 Global Modified Antibody Market Value by Application (2024 VS 2031)
1.3.2 Cancer Treatment
1.3.3 Immunopathy Treatment
1.3.4 Diagnosis
1.3.5 Scientific Research
1.3.6 Others
1.4 Global Modified Antibody Market Size Estimates and Forecasts
1.4.1 Global Modified Antibody Revenue 2020-2031
1.4.2 Global Modified Antibody Sales 2020-2031
1.4.3 Global Modified Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Modified Antibody Market Competition by Manufacturers
2.1 Global Modified Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Modified Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Modified Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Modified Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Modified Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Modified Antibody, Product Type & Application
2.7 Global Key Manufacturers of Modified Antibody, Date of Enter into This Industry
2.8 Global Modified Antibody Market Competitive Situation and Trends
2.8.1 Global Modified Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Modified Antibody Players Market Share by Revenue
2.8.3 Global Modified Antibody Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Modified Antibody Market Scenario by Region
3.1 Global Modified Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Modified Antibody Sales by Region: 2020-2031
3.2.1 Global Modified Antibody Sales by Region: 2020-2025
3.2.2 Global Modified Antibody Sales by Region: 2026-2031
3.3 Global Modified Antibody Revenue by Region: 2020-2031
3.3.1 Global Modified Antibody Revenue by Region: 2020-2025
3.3.2 Global Modified Antibody Revenue by Region: 2026-2031
3.4 North America Modified Antibody Market Facts & Figures by Country
3.4.1 North America Modified Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Modified Antibody Sales by Country (2020-2031)
3.4.3 North America Modified Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Modified Antibody Market Facts & Figures by Country
3.5.1 Europe Modified Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Modified Antibody Sales by Country (2020-2031)
3.5.3 Europe Modified Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Modified Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Modified Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Modified Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Modified Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Modified Antibody Market Facts & Figures by Country
3.7.1 Latin America Modified Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Modified Antibody Sales by Country (2020-2031)
3.7.3 Latin America Modified Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Modified Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Modified Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Modified Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Modified Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Modified Antibody Sales by Type (2020-2031)
4.1.1 Global Modified Antibody Sales by Type (2020-2025)
4.1.2 Global Modified Antibody Sales by Type (2026-2031)
4.1.3 Global Modified Antibody Sales Market Share by Type (2020-2031)
4.2 Global Modified Antibody Revenue by Type (2020-2031)
4.2.1 Global Modified Antibody Revenue by Type (2020-2025)
4.2.2 Global Modified Antibody Revenue by Type (2026-2031)
4.2.3 Global Modified Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Modified Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Modified Antibody Sales by Application (2020-2031)
5.1.1 Global Modified Antibody Sales by Application (2020-2025)
5.1.2 Global Modified Antibody Sales by Application (2026-2031)
5.1.3 Global Modified Antibody Sales Market Share by Application (2020-2031)
5.2 Global Modified Antibody Revenue by Application (2020-2031)
5.2.1 Global Modified Antibody Revenue by Application (2020-2025)
5.2.2 Global Modified Antibody Revenue by Application (2026-2031)
5.2.3 Global Modified Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Modified Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 RevMAb Biosciences
6.1.1 RevMAb Biosciences Company Information
6.1.2 RevMAb Biosciences Description and Business Overview
6.1.3 RevMAb Biosciences Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 RevMAb Biosciences Modified Antibody Product Portfolio
6.1.5 RevMAb Biosciences Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thermo Fisher Scientific Modified Antibody Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 BioCat GmbH
6.3.1 BioCat GmbH Company Information
6.3.2 BioCat GmbH Description and Business Overview
6.3.3 BioCat GmbH Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BioCat GmbH Modified Antibody Product Portfolio
6.3.5 BioCat GmbH Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Modified Antibody Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 ProteoGenix
6.5.1 ProteoGenix Company Information
6.5.2 ProteoGenix Description and Business Overview
6.5.3 ProteoGenix Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 ProteoGenix Modified Antibody Product Portfolio
6.5.5 ProteoGenix Recent Developments/Updates
6.6 Biorbyt
6.6.1 Biorbyt Company Information
6.6.2 Biorbyt Description and Business Overview
6.6.3 Biorbyt Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Biorbyt Modified Antibody Product Portfolio
6.6.5 Biorbyt Recent Developments/Updates
6.7 Cusabio
6.7.1 Cusabio Company Information
6.7.2 Cusabio Description and Business Overview
6.7.3 Cusabio Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cusabio Modified Antibody Product Portfolio
6.7.5 Cusabio Recent Developments/Updates
6.8 Rockland
6.8.1 Rockland Company Information
6.8.2 Rockland Description and Business Overview
6.8.3 Rockland Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Rockland Modified Antibody Product Portfolio
6.8.5 Rockland Recent Developments/Updates
6.9 Proteintech
6.9.1 Proteintech Company Information
6.9.2 Proteintech Description and Business Overview
6.9.3 Proteintech Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Proteintech Modified Antibody Product Portfolio
6.9.5 Proteintech Recent Developments/Updates
6.10 PTM BIO
6.10.1 PTM BIO Company Information
6.10.2 PTM BIO Description and Business Overview
6.10.3 PTM BIO Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 PTM BIO Modified Antibody Product Portfolio
6.10.5 PTM BIO Recent Developments/Updates
6.11 Elabscience Biotechnology
6.11.1 Elabscience Biotechnology Company Information
6.11.2 Elabscience Biotechnology Description and Business Overview
6.11.3 Elabscience Biotechnology Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Elabscience Biotechnology Modified Antibody Product Portfolio
6.11.5 Elabscience Biotechnology Recent Developments/Updates
6.12 AtaGenix
6.12.1 AtaGenix Company Information
6.12.2 AtaGenix Description and Business Overview
6.12.3 AtaGenix Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 AtaGenix Modified Antibody Product Portfolio
6.12.5 AtaGenix Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Modified Antibody Industry Chain Analysis
7.2 Modified Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Modified Antibody Production Mode & Process Analysis
7.4 Modified Antibody Sales and Marketing
7.4.1 Modified Antibody Sales Channels
7.4.2 Modified Antibody Distributors
7.5 Modified Antibody Customer Analysis
8 Modified Antibody Market Dynamics
8.1 Modified Antibody Industry Trends
8.2 Modified Antibody Market Drivers
8.3 Modified Antibody Market Challenges
8.4 Modified Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Modified Antibody by Type
1.2.1 Global Modified Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Histone Modification Antibodies
1.2.3 Non-Histone Modification Antibodies
1.3 Modified Antibody by Application
1.3.1 Global Modified Antibody Market Value by Application (2024 VS 2031)
1.3.2 Cancer Treatment
1.3.3 Immunopathy Treatment
1.3.4 Diagnosis
1.3.5 Scientific Research
1.3.6 Others
1.4 Global Modified Antibody Market Size Estimates and Forecasts
1.4.1 Global Modified Antibody Revenue 2020-2031
1.4.2 Global Modified Antibody Sales 2020-2031
1.4.3 Global Modified Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Modified Antibody Market Competition by Manufacturers
2.1 Global Modified Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Modified Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Modified Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Modified Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Modified Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Modified Antibody, Product Type & Application
2.7 Global Key Manufacturers of Modified Antibody, Date of Enter into This Industry
2.8 Global Modified Antibody Market Competitive Situation and Trends
2.8.1 Global Modified Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Modified Antibody Players Market Share by Revenue
2.8.3 Global Modified Antibody Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Modified Antibody Market Scenario by Region
3.1 Global Modified Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Modified Antibody Sales by Region: 2020-2031
3.2.1 Global Modified Antibody Sales by Region: 2020-2025
3.2.2 Global Modified Antibody Sales by Region: 2026-2031
3.3 Global Modified Antibody Revenue by Region: 2020-2031
3.3.1 Global Modified Antibody Revenue by Region: 2020-2025
3.3.2 Global Modified Antibody Revenue by Region: 2026-2031
3.4 North America Modified Antibody Market Facts & Figures by Country
3.4.1 North America Modified Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Modified Antibody Sales by Country (2020-2031)
3.4.3 North America Modified Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Modified Antibody Market Facts & Figures by Country
3.5.1 Europe Modified Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Modified Antibody Sales by Country (2020-2031)
3.5.3 Europe Modified Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Modified Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Modified Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Modified Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Modified Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Modified Antibody Market Facts & Figures by Country
3.7.1 Latin America Modified Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Modified Antibody Sales by Country (2020-2031)
3.7.3 Latin America Modified Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Modified Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Modified Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Modified Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Modified Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Modified Antibody Sales by Type (2020-2031)
4.1.1 Global Modified Antibody Sales by Type (2020-2025)
4.1.2 Global Modified Antibody Sales by Type (2026-2031)
4.1.3 Global Modified Antibody Sales Market Share by Type (2020-2031)
4.2 Global Modified Antibody Revenue by Type (2020-2031)
4.2.1 Global Modified Antibody Revenue by Type (2020-2025)
4.2.2 Global Modified Antibody Revenue by Type (2026-2031)
4.2.3 Global Modified Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Modified Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Modified Antibody Sales by Application (2020-2031)
5.1.1 Global Modified Antibody Sales by Application (2020-2025)
5.1.2 Global Modified Antibody Sales by Application (2026-2031)
5.1.3 Global Modified Antibody Sales Market Share by Application (2020-2031)
5.2 Global Modified Antibody Revenue by Application (2020-2031)
5.2.1 Global Modified Antibody Revenue by Application (2020-2025)
5.2.2 Global Modified Antibody Revenue by Application (2026-2031)
5.2.3 Global Modified Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Modified Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 RevMAb Biosciences
6.1.1 RevMAb Biosciences Company Information
6.1.2 RevMAb Biosciences Description and Business Overview
6.1.3 RevMAb Biosciences Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 RevMAb Biosciences Modified Antibody Product Portfolio
6.1.5 RevMAb Biosciences Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thermo Fisher Scientific Modified Antibody Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 BioCat GmbH
6.3.1 BioCat GmbH Company Information
6.3.2 BioCat GmbH Description and Business Overview
6.3.3 BioCat GmbH Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BioCat GmbH Modified Antibody Product Portfolio
6.3.5 BioCat GmbH Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Modified Antibody Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 ProteoGenix
6.5.1 ProteoGenix Company Information
6.5.2 ProteoGenix Description and Business Overview
6.5.3 ProteoGenix Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 ProteoGenix Modified Antibody Product Portfolio
6.5.5 ProteoGenix Recent Developments/Updates
6.6 Biorbyt
6.6.1 Biorbyt Company Information
6.6.2 Biorbyt Description and Business Overview
6.6.3 Biorbyt Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Biorbyt Modified Antibody Product Portfolio
6.6.5 Biorbyt Recent Developments/Updates
6.7 Cusabio
6.7.1 Cusabio Company Information
6.7.2 Cusabio Description and Business Overview
6.7.3 Cusabio Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cusabio Modified Antibody Product Portfolio
6.7.5 Cusabio Recent Developments/Updates
6.8 Rockland
6.8.1 Rockland Company Information
6.8.2 Rockland Description and Business Overview
6.8.3 Rockland Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Rockland Modified Antibody Product Portfolio
6.8.5 Rockland Recent Developments/Updates
6.9 Proteintech
6.9.1 Proteintech Company Information
6.9.2 Proteintech Description and Business Overview
6.9.3 Proteintech Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Proteintech Modified Antibody Product Portfolio
6.9.5 Proteintech Recent Developments/Updates
6.10 PTM BIO
6.10.1 PTM BIO Company Information
6.10.2 PTM BIO Description and Business Overview
6.10.3 PTM BIO Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 PTM BIO Modified Antibody Product Portfolio
6.10.5 PTM BIO Recent Developments/Updates
6.11 Elabscience Biotechnology
6.11.1 Elabscience Biotechnology Company Information
6.11.2 Elabscience Biotechnology Description and Business Overview
6.11.3 Elabscience Biotechnology Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Elabscience Biotechnology Modified Antibody Product Portfolio
6.11.5 Elabscience Biotechnology Recent Developments/Updates
6.12 AtaGenix
6.12.1 AtaGenix Company Information
6.12.2 AtaGenix Description and Business Overview
6.12.3 AtaGenix Modified Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 AtaGenix Modified Antibody Product Portfolio
6.12.5 AtaGenix Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Modified Antibody Industry Chain Analysis
7.2 Modified Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Modified Antibody Production Mode & Process Analysis
7.4 Modified Antibody Sales and Marketing
7.4.1 Modified Antibody Sales Channels
7.4.2 Modified Antibody Distributors
7.5 Modified Antibody Customer Analysis
8 Modified Antibody Market Dynamics
8.1 Modified Antibody Industry Trends
8.2 Modified Antibody Market Drivers
8.3 Modified Antibody Market Challenges
8.4 Modified Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Modified Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Modified Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Modified Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global Modified Antibody Sales (μl) of Key Manufacturers (2020-2025)
Table 5. Global Modified Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Modified Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Modified Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Modified Antibody Average Price (US$/μl) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Modified Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Modified Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Modified Antibody, Product Type & Application
Table 12. Global Key Manufacturers of Modified Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Modified Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Modified Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Modified Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Modified Antibody Sales by Region (2020-2025) & (μl)
Table 18. Global Modified Antibody Sales Market Share by Region (2020-2025)
Table 19. Global Modified Antibody Sales by Region (2026-2031) & (μl)
Table 20. Global Modified Antibody Sales Market Share by Region (2026-2031)
Table 21. Global Modified Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Modified Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global Modified Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Modified Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America Modified Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Modified Antibody Sales by Country (2020-2025) & (μl)
Table 27. North America Modified Antibody Sales by Country (2026-2031) & (μl)
Table 28. North America Modified Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Modified Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Modified Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Modified Antibody Sales by Country (2020-2025) & (μl)
Table 32. Europe Modified Antibody Sales by Country (2026-2031) & (μl)
Table 33. Europe Modified Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Modified Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Modified Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Modified Antibody Sales by Region (2020-2025) & (μl)
Table 37. Asia Pacific Modified Antibody Sales by Region (2026-2031) & (μl)
Table 38. Asia Pacific Modified Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Modified Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Modified Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Modified Antibody Sales by Country (2020-2025) & (μl)
Table 42. Latin America Modified Antibody Sales by Country (2026-2031) & (μl)
Table 43. Latin America Modified Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Modified Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Modified Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Modified Antibody Sales by Country (2020-2025) & (μl)
Table 47. Middle East and Africa Modified Antibody Sales by Country (2026-2031) & (μl)
Table 48. Middle East and Africa Modified Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Modified Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Modified Antibody Sales (μl) by Type (2020-2025)
Table 51. Global Modified Antibody Sales (μl) by Type (2026-2031)
Table 52. Global Modified Antibody Sales Market Share by Type (2020-2025)
Table 53. Global Modified Antibody Sales Market Share by Type (2026-2031)
Table 54. Global Modified Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Modified Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Modified Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global Modified Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global Modified Antibody Price (US$/μl) by Type (2020-2025)
Table 59. Global Modified Antibody Price (US$/μl) by Type (2026-2031)
Table 60. Global Modified Antibody Sales (μl) by Application (2020-2025)
Table 61. Global Modified Antibody Sales (μl) by Application (2026-2031)
Table 62. Global Modified Antibody Sales Market Share by Application (2020-2025)
Table 63. Global Modified Antibody Sales Market Share by Application (2026-2031)
Table 64. Global Modified Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Modified Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Modified Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global Modified Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global Modified Antibody Price (US$/μl) by Application (2020-2025)
Table 69. Global Modified Antibody Price (US$/μl) by Application (2026-2031)
Table 70. RevMAb Biosciences Company Information
Table 71. RevMAb Biosciences Description and Business Overview
Table 72. RevMAb Biosciences Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 73. RevMAb Biosciences Modified Antibody Product
Table 74. RevMAb Biosciences Recent Developments/Updates
Table 75. Thermo Fisher Scientific Company Information
Table 76. Thermo Fisher Scientific Description and Business Overview
Table 77. Thermo Fisher Scientific Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 78. Thermo Fisher Scientific Modified Antibody Product
Table 79. Thermo Fisher Scientific Recent Developments/Updates
Table 80. BioCat GmbH Company Information
Table 81. BioCat GmbH Description and Business Overview
Table 82. BioCat GmbH Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 83. BioCat GmbH Modified Antibody Product
Table 84. BioCat GmbH Recent Developments/Updates
Table 85. Merck Company Information
Table 86. Merck Description and Business Overview
Table 87. Merck Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 88. Merck Modified Antibody Product
Table 89. Merck Recent Developments/Updates
Table 90. ProteoGenix Company Information
Table 91. ProteoGenix Description and Business Overview
Table 92. ProteoGenix Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 93. ProteoGenix Modified Antibody Product
Table 94. ProteoGenix Recent Developments/Updates
Table 95. Biorbyt Company Information
Table 96. Biorbyt Description and Business Overview
Table 97. Biorbyt Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 98. Biorbyt Modified Antibody Product
Table 99. Biorbyt Recent Developments/Updates
Table 100. Cusabio Company Information
Table 101. Cusabio Description and Business Overview
Table 102. Cusabio Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 103. Cusabio Modified Antibody Product
Table 104. Cusabio Recent Developments/Updates
Table 105. Rockland Company Information
Table 106. Rockland Description and Business Overview
Table 107. Rockland Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 108. Rockland Modified Antibody Product
Table 109. Rockland Recent Developments/Updates
Table 110. Proteintech Company Information
Table 111. Proteintech Description and Business Overview
Table 112. Proteintech Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 113. Proteintech Modified Antibody Product
Table 114. Proteintech Recent Developments/Updates
Table 115. PTM BIO Company Information
Table 116. PTM BIO Description and Business Overview
Table 117. PTM BIO Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 118. PTM BIO Modified Antibody Product
Table 119. PTM BIO Recent Developments/Updates
Table 120. Elabscience Biotechnology Company Information
Table 121. Elabscience Biotechnology Description and Business Overview
Table 122. Elabscience Biotechnology Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 123. Elabscience Biotechnology Modified Antibody Product
Table 124. Elabscience Biotechnology Recent Developments/Updates
Table 125. AtaGenix Company Information
Table 126. AtaGenix Description and Business Overview
Table 127. AtaGenix Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 128. AtaGenix Modified Antibody Product
Table 129. AtaGenix Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Modified Antibody Distributors List
Table 133. Modified Antibody Customers List
Table 134. Modified Antibody Market Trends
Table 135. Modified Antibody Market Drivers
Table 136. Modified Antibody Market Challenges
Table 137. Modified Antibody Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Modified Antibody
Figure 2. Global Modified Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Modified Antibody Market Share by Type: 2024 & 2031
Figure 4. Histone Modification Antibodies Product Picture
Figure 5. Non-Histone Modification Antibodies Product Picture
Figure 6. Global Modified Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Modified Antibody Market Share by Application: 2024 & 2031
Figure 8. Cancer Treatment
Figure 9. Immunopathy Treatment
Figure 10. Diagnosis
Figure 11. Scientific Research
Figure 12. Others
Figure 13. Global Modified Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Modified Antibody Market Size (2020-2031) & (US$ Million)
Figure 15. Global Modified Antibody Sales (2020-2031) & (μl)
Figure 16. Global Modified Antibody Average Price (US$/μl) & (2020-2031)
Figure 17. Modified Antibody Report Years Considered
Figure 18. Modified Antibody Sales Share by Manufacturers in 2024
Figure 19. Global Modified Antibody Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Modified Antibody Players: Market Share by Revenue in Modified Antibody in 2024
Figure 21. Modified Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Modified Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Modified Antibody Sales Market Share by Country (2020-2031)
Figure 24. North America Modified Antibody Revenue Market Share by Country (2020-2031)
Figure 25. United States Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Modified Antibody Sales Market Share by Country (2020-2031)
Figure 28. Europe Modified Antibody Revenue Market Share by Country (2020-2031)
Figure 29. Germany Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Modified Antibody Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Modified Antibody Revenue Market Share by Region (2020-2031)
Figure 36. China Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Modified Antibody Sales Market Share by Country (2020-2031)
Figure 44. Latin America Modified Antibody Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Modified Antibody Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Modified Antibody Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Modified Antibody by Type (2020-2031)
Figure 55. Global Revenue Market Share of Modified Antibody by Type (2020-2031)
Figure 56. Global Modified Antibody Price (US$/μl) by Type (2020-2031)
Figure 57. Global Sales Market Share of Modified Antibody by Application (2020-2031)
Figure 58. Global Revenue Market Share of Modified Antibody by Application (2020-2031)
Figure 59. Global Modified Antibody Price (US$/μl) by Application (2020-2031)
Figure 60. Modified Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Modified Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Modified Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Modified Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global Modified Antibody Sales (μl) of Key Manufacturers (2020-2025)
Table 5. Global Modified Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Modified Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Modified Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Modified Antibody Average Price (US$/μl) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Modified Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Modified Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Modified Antibody, Product Type & Application
Table 12. Global Key Manufacturers of Modified Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Modified Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Modified Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Modified Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Modified Antibody Sales by Region (2020-2025) & (μl)
Table 18. Global Modified Antibody Sales Market Share by Region (2020-2025)
Table 19. Global Modified Antibody Sales by Region (2026-2031) & (μl)
Table 20. Global Modified Antibody Sales Market Share by Region (2026-2031)
Table 21. Global Modified Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Modified Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global Modified Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Modified Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America Modified Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Modified Antibody Sales by Country (2020-2025) & (μl)
Table 27. North America Modified Antibody Sales by Country (2026-2031) & (μl)
Table 28. North America Modified Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Modified Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Modified Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Modified Antibody Sales by Country (2020-2025) & (μl)
Table 32. Europe Modified Antibody Sales by Country (2026-2031) & (μl)
Table 33. Europe Modified Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Modified Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Modified Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Modified Antibody Sales by Region (2020-2025) & (μl)
Table 37. Asia Pacific Modified Antibody Sales by Region (2026-2031) & (μl)
Table 38. Asia Pacific Modified Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Modified Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Modified Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Modified Antibody Sales by Country (2020-2025) & (μl)
Table 42. Latin America Modified Antibody Sales by Country (2026-2031) & (μl)
Table 43. Latin America Modified Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Modified Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Modified Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Modified Antibody Sales by Country (2020-2025) & (μl)
Table 47. Middle East and Africa Modified Antibody Sales by Country (2026-2031) & (μl)
Table 48. Middle East and Africa Modified Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Modified Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Modified Antibody Sales (μl) by Type (2020-2025)
Table 51. Global Modified Antibody Sales (μl) by Type (2026-2031)
Table 52. Global Modified Antibody Sales Market Share by Type (2020-2025)
Table 53. Global Modified Antibody Sales Market Share by Type (2026-2031)
Table 54. Global Modified Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Modified Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Modified Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global Modified Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global Modified Antibody Price (US$/μl) by Type (2020-2025)
Table 59. Global Modified Antibody Price (US$/μl) by Type (2026-2031)
Table 60. Global Modified Antibody Sales (μl) by Application (2020-2025)
Table 61. Global Modified Antibody Sales (μl) by Application (2026-2031)
Table 62. Global Modified Antibody Sales Market Share by Application (2020-2025)
Table 63. Global Modified Antibody Sales Market Share by Application (2026-2031)
Table 64. Global Modified Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Modified Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Modified Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global Modified Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global Modified Antibody Price (US$/μl) by Application (2020-2025)
Table 69. Global Modified Antibody Price (US$/μl) by Application (2026-2031)
Table 70. RevMAb Biosciences Company Information
Table 71. RevMAb Biosciences Description and Business Overview
Table 72. RevMAb Biosciences Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 73. RevMAb Biosciences Modified Antibody Product
Table 74. RevMAb Biosciences Recent Developments/Updates
Table 75. Thermo Fisher Scientific Company Information
Table 76. Thermo Fisher Scientific Description and Business Overview
Table 77. Thermo Fisher Scientific Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 78. Thermo Fisher Scientific Modified Antibody Product
Table 79. Thermo Fisher Scientific Recent Developments/Updates
Table 80. BioCat GmbH Company Information
Table 81. BioCat GmbH Description and Business Overview
Table 82. BioCat GmbH Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 83. BioCat GmbH Modified Antibody Product
Table 84. BioCat GmbH Recent Developments/Updates
Table 85. Merck Company Information
Table 86. Merck Description and Business Overview
Table 87. Merck Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 88. Merck Modified Antibody Product
Table 89. Merck Recent Developments/Updates
Table 90. ProteoGenix Company Information
Table 91. ProteoGenix Description and Business Overview
Table 92. ProteoGenix Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 93. ProteoGenix Modified Antibody Product
Table 94. ProteoGenix Recent Developments/Updates
Table 95. Biorbyt Company Information
Table 96. Biorbyt Description and Business Overview
Table 97. Biorbyt Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 98. Biorbyt Modified Antibody Product
Table 99. Biorbyt Recent Developments/Updates
Table 100. Cusabio Company Information
Table 101. Cusabio Description and Business Overview
Table 102. Cusabio Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 103. Cusabio Modified Antibody Product
Table 104. Cusabio Recent Developments/Updates
Table 105. Rockland Company Information
Table 106. Rockland Description and Business Overview
Table 107. Rockland Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 108. Rockland Modified Antibody Product
Table 109. Rockland Recent Developments/Updates
Table 110. Proteintech Company Information
Table 111. Proteintech Description and Business Overview
Table 112. Proteintech Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 113. Proteintech Modified Antibody Product
Table 114. Proteintech Recent Developments/Updates
Table 115. PTM BIO Company Information
Table 116. PTM BIO Description and Business Overview
Table 117. PTM BIO Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 118. PTM BIO Modified Antibody Product
Table 119. PTM BIO Recent Developments/Updates
Table 120. Elabscience Biotechnology Company Information
Table 121. Elabscience Biotechnology Description and Business Overview
Table 122. Elabscience Biotechnology Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 123. Elabscience Biotechnology Modified Antibody Product
Table 124. Elabscience Biotechnology Recent Developments/Updates
Table 125. AtaGenix Company Information
Table 126. AtaGenix Description and Business Overview
Table 127. AtaGenix Modified Antibody Sales (μl), Revenue (US$ Million), Price (US$/μl) and Gross Margin (2020-2025)
Table 128. AtaGenix Modified Antibody Product
Table 129. AtaGenix Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Modified Antibody Distributors List
Table 133. Modified Antibody Customers List
Table 134. Modified Antibody Market Trends
Table 135. Modified Antibody Market Drivers
Table 136. Modified Antibody Market Challenges
Table 137. Modified Antibody Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Modified Antibody
Figure 2. Global Modified Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Modified Antibody Market Share by Type: 2024 & 2031
Figure 4. Histone Modification Antibodies Product Picture
Figure 5. Non-Histone Modification Antibodies Product Picture
Figure 6. Global Modified Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Modified Antibody Market Share by Application: 2024 & 2031
Figure 8. Cancer Treatment
Figure 9. Immunopathy Treatment
Figure 10. Diagnosis
Figure 11. Scientific Research
Figure 12. Others
Figure 13. Global Modified Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Modified Antibody Market Size (2020-2031) & (US$ Million)
Figure 15. Global Modified Antibody Sales (2020-2031) & (μl)
Figure 16. Global Modified Antibody Average Price (US$/μl) & (2020-2031)
Figure 17. Modified Antibody Report Years Considered
Figure 18. Modified Antibody Sales Share by Manufacturers in 2024
Figure 19. Global Modified Antibody Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Modified Antibody Players: Market Share by Revenue in Modified Antibody in 2024
Figure 21. Modified Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Modified Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Modified Antibody Sales Market Share by Country (2020-2031)
Figure 24. North America Modified Antibody Revenue Market Share by Country (2020-2031)
Figure 25. United States Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Modified Antibody Sales Market Share by Country (2020-2031)
Figure 28. Europe Modified Antibody Revenue Market Share by Country (2020-2031)
Figure 29. Germany Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Modified Antibody Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Modified Antibody Revenue Market Share by Region (2020-2031)
Figure 36. China Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Modified Antibody Sales Market Share by Country (2020-2031)
Figure 44. Latin America Modified Antibody Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Modified Antibody Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Modified Antibody Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Modified Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Modified Antibody by Type (2020-2031)
Figure 55. Global Revenue Market Share of Modified Antibody by Type (2020-2031)
Figure 56. Global Modified Antibody Price (US$/μl) by Type (2020-2031)
Figure 57. Global Sales Market Share of Modified Antibody by Application (2020-2031)
Figure 58. Global Revenue Market Share of Modified Antibody by Application (2020-2031)
Figure 59. Global Modified Antibody Price (US$/μl) by Application (2020-2031)
Figure 60. Modified Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global LED Light Housing Market Research Report 2025
Sep 24, 25
Global Side Emitting LED Strip Light Market Research Report 2025
Sep 24, 25
Global Medium and Low Voltage Unshielded Cable Market Research Report 2025
Sep 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232